Table 2.

Antisense oligonucleotides used in this study. The 5' to 3' sequence is indicated from left to right.

HIV-2 asΨ	CTA GGA GCA CTC CGT CGT GGT TTG
HIV-2 asSL1	TGG TAC CTC GGC CCG CGC CT
HIV-2 asC	CTA GGA GAG ATG GGA GTA CAC AC
HIV-2 asG	CAT CTC CCA CAA TCT TCT ACC
SIV asΨ	ATA GGA GCA CTC CGT CGT GGT TGG
SIV asSL1	TGG TAC CGA CCC GCG CCT
SIV asC	CTA GGA GAG ATG GGA ACA CAC AC
SIV asG	CAT CTC CCA CTC TAT CTT ATT ACC CC
HIV-1 as246	CGA GTC CTG CGT CGA GAG ATC TCC
HIV-1 asSL1	TGC GCG CTT CAG CAA GCC GAG TCC
HIV-1 asC	AGA CGG GCA CAC ACT ACT TTG AGC A
HIV-1 asG	CAT CTC TCT CCT TCT AGC CTC